Canadian Biotech Stocks

Green Thumb Industries

Market Cap: CA$2.3b

Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.

Curaleaf Holdings

Market Cap: CA$2.1b

Produces and distributes cannabis products in the United States and internationally.

Trulieve Cannabis

Market Cap: CA$1.5b

Operates as a cannabis retailer.

Knight Therapeutics

Market Cap: CA$630.8m

Focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.

Verano Holdings

Market Cap: CA$470.3m

Operates as a vertically integrated multi-state cannabis operator in the United States.

Cresco Labs

Market Cap: CA$452.8m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States.

Bright Minds Biosciences

Market Cap: CA$379.4m

A biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States.

Aurora Cannabis

Market Cap: CA$348.3m

Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.

TerrAscend

Market Cap: CA$273.6m

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.

Organigram Global

Market Cap: CA$265.1m

Engages in the production and sale of cannabis and cannabis-derived products in Canada.

High Tide

Market Cap: CA$241.2m

Engages in the cannabis retail business in Canada.

Auxly Cannabis Group

Market Cap: CA$188.2m

Operates as a consumer packaged goods company in the cannabis products market in Canada.

HLS Therapeutics

Market Cap: CA$158.4m

A specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders, central nervous system, and cardiovascular disease in Canada, the United States, and internationally.

Grown Rogue International

Market Cap: CA$137.2m

A craft cannabis company, focuses on premium flower and flower-derived products.

Cardiol Therapeutics

Market Cap: CA$115.7m

A clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.

Oncolytics Biotech

Market Cap: CA$114.0m

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments.

Planet 13 Holdings

Market Cap: CA$107.4m

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.

Satellos Bioscience

Market Cap: CA$100.5m

A biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia.

MTL Cannabis

Market Cap: CA$87.7m

Through its subsidiaries, engages in the cultivation and production of cannabis products for recreational and medical purposes in Canada.

Medexus Pharmaceuticals

Market Cap: CA$84.2m

Operates as a pharmaceutical company in Canada and the United States.

Covalon Technologies

Market Cap: CA$67.2m

Engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally.

Decibel Cannabis

Market Cap: CA$60.6m

An integrated cannabis company, engages in the cannabis cultivation in Canada.

Microbix Biosystems

Market Cap: CA$40.6m

A life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally.

Rubicon Organics

Market Cap: CA$34.9m

Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.

1CM

Market Cap: CA$31.8m

Operates as a multi-jurisdictional cannabis company in Canada.

MediPharm Labs

Market Cap: CA$29.1m

Operates as a pharmaceutical company that produces and sells purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally.

Devonian Health Group

Market Cap: CA$24.5m

Engages in the development of botanical drugs.

Charlotte's Web Holdings

Market Cap: CA$22.3m

Engages in the farming, manufacturing, marketing, and sale of hemp-derived cannabidiol (CBD) and other botanical-based wellness products.

Telescope Innovations

Market Cap: CA$20.9m

A chemical technology company, develops manufacturing processes and tools for the pharmaceutical and chemical industry in the United States and Canada.

Ayr Wellness

Market Cap: CA$18.1m

Ayr Wellness Inc. cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods.

BriaCell Therapeutics

Market Cap: CA$17.2m

A clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care.

Numinus Wellness

Market Cap: CA$16.1m

Provides psychedelic-assisted psychotherapy products and services in Canada and the United States.

COSCIENS Biopharma

Market Cap: CA$15.5m

A life science company, develops and commercializes products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, Colombia, the United Kingdom, and internationally.

SOL Global Investments

Market Cap: CA$13.8m

A private equity firm specializing in growth capital to small and mid-sized businesses.

Medicure

Market Cap: CA$11.6m

A biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States.

Christina Lake Cannabis

Market Cap: CA$11.2m

A license cannabis producer, engages in the research and development, cultivation, processing, production, and sale of cannabis in Canada.